Meningitis-ME/CFS Intersection
3 Sorensen et al. 2003 — Exercise-Induced Complement Activation in CFS
Full Citation:: Sorensen B, Streib JE, Strand M et al. Complement activation in a model of chronic fatigue syndrome. Journal of Allergy and Clinical Immunology. 2003;112(2):397–403. DOI:: 10.1067/mai.2003.1615 PMID:: 12897748 Study Design:: Controlled exercise challenge; 32 CFS patients, 29 healthy controls Key Findings::
- Significant C4a elevation at 6 hours post-exercise only in CFS group ($P\\<0.01$)
- C4a elevation occurred regardless of allergy status
- First demonstration of exercise-induced complement activation in CFS
- Implicates the lectin and/or classical complement pathways in PEMRelevance:: Foundational study linking complement system to PEM mechanism. Subsequently replicated and extended by Nijs 2010 (Nijs et al. 2010), Polli 2019 (Polli et al. 2019), and Glass 2025 (Glass et al. 2025) (extracellular vesicle proteomics). The complement–PEM link also connects to meningococcal susceptibility considerations, as complement dysfunction is the strongest known risk factor for invasive meningococcal disease (though the specific pathway differs). Certainty Assessment::
- *Quality:* High (controlled exercise challenge, rigorous design)
- *Sample:* $n=61$ total
- *Replication:* Replicated across three independent groups (Nijs, Polli, Glass/Hanson)
- *Certainty:* 0.75 (robust replication; specific mechanism well-characterized)4 Iu et al. 2024 — CD8+ T Cell Exhaustion in ME/CFS
Full Citation:: Iu DS, Maya J, Vu LT et al. Transcriptional reprogramming primes CD8+ T cells toward exhaustion in ME/CFS. Proceedings of the National Academy of Sciences. 2024;121(50):e2415119121. DOI:: 10.1073/pnas.2415119121 PMID:: 39621903 Study Design:: Multi-omics (transcriptomics, epigenomics) characterisation of CD8+ T cells Key Findings::
- Elevated exhaustion markers: SLAMF6, SLAMF7, EOMES, TOX
- Altered metabolic programming with epigenetic signatures of exhaustion
- Demonstrates transcriptional reprogramming toward exhaustion, not merely activation-induced downregulation
- Consistent with chronic antigen stimulation modelRelevance:: Landmark study from the Hanson lab (Cornell). Establishes that ME/CFS CD8+ T cell dysfunction is an epigenetically programmed state rather than transient activation. Has direct implications for infection susceptibility (exhausted T cells cannot mount effective secondary responses) and vaccine efficacy (whether exhausted T cells can respond to vaccine antigens). The exhaustion phenotype overlaps with Long COVID CD8+ dysfunction (Gil et al. 2023). Certainty Assessment::
- *Quality:* High (PNAS; multi-omics; rigorous methodology)
- *Replication:* Consistent with Gil 2023 (CD8 dysfunction shared with Long COVID)
- *Certainty:* 0.70 (strong methodology; awaits independent replication)5 Pi {nas et al. 2022 — Glymphatic Dysfunction in Pneumococcal Meningitis}
Full Citation:: Pi {n}as G et al. Glymphatic system dysfunction in pneumococcal meningitis. mBio. 2022. DOI:: 10.1128/mbio.02350-22 PMID:: 36286550 Study Design:: Preclinical (murine pneumococcal meningitis model) Key Findings::
- Progressive retraction of astrocytic endfeet from vascular endothelium
- Misplacement of AQP4 water channels preventing CSF-interstitial fluid exchange
- Accumulation of bacterial toxins (pneumolysin) in CSF compartments
- Increased microglial activation, brain damage, and memory impairmentRelevance:: Proposes glymphatic dysfunction as “a new pathomechanism in pneumococcal meningitis” explaining long-term neurological sequelae. Directly parallels the ME/CFS glymphatic dysfunction hypothesis (Perrin et al. 2025). The AQP4 misplacement mechanism provides a specific molecular target that could be assessed in ME/CFS patients via post-mortem studies or advanced MRI techniques. Certainty Assessment::
- *Quality:* High (mBio; well-controlled animal model)
- *Replication:* Novel finding; not yet replicated
- *Certainty:* 0.55 (animal model; human translation uncertain)6 Christodoulides et al. 2025 — Dural Mast Cells Regulate CSF Dynamics
Full Citation:: Christodoulides M et al. Dural mast cells regulate CSF dynamics at arachnoid cuff exit points. Cell. 2025. DOI:: 10.1016/j.cell.2025.06.046 PMID:: 40712577 Study Design:: Preclinical (murine); combining mast cell-deficient mice, bacterial meningitis models, and advanced CSF imaging Key Findings::
- Dural mast cells regulate CSF dynamics at arachnoid cuff exit (ACE) points
- During meningitis, mast cell activation redirects CSF flow and recruits neutrophils
- Mice lacking dural mast cells had impaired immune responses and higher brain bacterial loads
- Histamine release induces vasodilation of bridging veins, reducing perivascular spaces for CSF drainageRelevance:: Landmark Cell paper creating a previously unrecognized mechanistic bridge between mast cell activation and glymphatic/CSF flow regulation. If chronic mast cell dysfunction (MCAS) disrupts CSF flow at ACE points, this connects the ME/CFS-associated MCAS phenotype to glymphatic waste clearance impairment via a non-inflammatory mechanism. This is the strongest mechanistic link between mast cell pathology and the cognitive symptoms of ME/CFS that does not invoke systemic inflammation. Certainty Assessment::
- *Quality:* Very high (Cell; rigorous multi-model approach)
- *Replication:* Novel discovery; not yet replicated
- *Certainty:* 0.60 (animal model; human translation pending; ME/CFS application is extrapolation)7 Magnus et al. 2015 — Infection, Not Vaccination, Triggers CFS/ME
Full Citation:: Magnus P et al. CFS/ME is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. 2015;33(46):6173–6177. DOI:: 10.1016/j.vaccine.2015.10.018 PMID:: 26475444 Study Design:: Population-based registry study; entire Norwegian population 2009–2012 Key Findings::
- Pandemic influenza infection: HR 2.04 (CI 1.78–2.33) for CFS/ME
- Adjuvanted pandemic vaccine (Pandemrix): HR 0.97 (no increased risk)
- Complete separation of infection risk from vaccination risk at population levelRelevance:: Definitive population-level evidence that infection, not antigen exposure, triggers CFS/ME. Combined with the meningococcal vaccine safety data (Magnus 2009, OR 1.06) (Magnus et al. 2009), establishes that vaccination is protective (prevents infection-triggered CFS/ME) without adding CFS/ME risk. Critical for clinical decision-making about vaccination in ME/CFS patients. Certainty Assessment::
- *Quality:* Very high (entire national population; registry-based)
- *Sample:* Millions of person-years
- *Certainty:* 0.85 (population-level data; definitive for influenza/Pandemrix; generalization to other vaccines is reasonable but not directly tested)